ATE303814T1 - Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos - Google Patents
Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikosInfo
- Publication number
- ATE303814T1 ATE303814T1 AT00945665T AT00945665T ATE303814T1 AT E303814 T1 ATE303814 T1 AT E303814T1 AT 00945665 T AT00945665 T AT 00945665T AT 00945665 T AT00945665 T AT 00945665T AT E303814 T1 ATE303814 T1 AT E303814T1
- Authority
- AT
- Austria
- Prior art keywords
- breast cancer
- estrogen
- composition
- risk
- steoridish
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199901034 | 1999-07-15 | ||
PCT/DK2000/000406 WO2001005415A2 (en) | 1999-07-15 | 2000-07-17 | Composition having steroidal estrogen effect without increasing the risk of breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE303814T1 true ATE303814T1 (de) | 2005-09-15 |
Family
ID=8100258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00945665T ATE303814T1 (de) | 1999-07-15 | 2000-07-17 | Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1200107B1 (de) |
AT (1) | ATE303814T1 (de) |
AU (1) | AU771581B2 (de) |
DE (1) | DE60022517T2 (de) |
DK (1) | DK1200107T3 (de) |
ES (1) | ES2249278T3 (de) |
WO (1) | WO2001005415A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2300783T3 (es) * | 2003-07-01 | 2008-06-16 | Max Zeller Sohne Ag | Procedimiento de extraccion vegetal y extracto. |
CA2654152A1 (en) | 2006-06-02 | 2007-12-13 | Pear Tree Women's Health Care | Method of treating atrophic vaginitis |
AU2013285492B2 (en) | 2012-07-03 | 2015-11-12 | Max Zeller Soehne Ag | Novel pharmacological use of Cimicifuga extract |
RU2680603C1 (ru) * | 2018-11-08 | 2019-02-25 | Ильясов Шамиль Сионович | Применение 3-о-сульфамата-16,16-диметил-d-гомоэквиленина для лечения онкологических заболеваний |
IT201900000343A1 (it) | 2019-01-10 | 2020-07-10 | Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L | Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19652183C1 (de) * | 1996-12-14 | 1998-02-12 | Schaper & Bruemmer Gmbh | Verwendung eines Extraktes aus Cimicifuga racemosa |
-
2000
- 2000-07-17 DK DK00945665T patent/DK1200107T3/da active
- 2000-07-17 AT AT00945665T patent/ATE303814T1/de not_active IP Right Cessation
- 2000-07-17 ES ES00945665T patent/ES2249278T3/es not_active Expired - Lifetime
- 2000-07-17 WO PCT/DK2000/000406 patent/WO2001005415A2/en active IP Right Grant
- 2000-07-17 DE DE60022517T patent/DE60022517T2/de not_active Expired - Fee Related
- 2000-07-17 AU AU59669/00A patent/AU771581B2/en not_active Ceased
- 2000-07-17 EP EP00945665A patent/EP1200107B1/de not_active Revoked
Also Published As
Publication number | Publication date |
---|---|
WO2001005415A3 (en) | 2001-05-25 |
EP1200107B1 (de) | 2005-09-07 |
DE60022517D1 (de) | 2005-10-13 |
WO2001005415A2 (en) | 2001-01-25 |
EP1200107A2 (de) | 2002-05-02 |
AU771581B2 (en) | 2004-03-25 |
DE60022517T2 (de) | 2006-08-03 |
DK1200107T3 (da) | 2006-01-16 |
AU5966900A (en) | 2001-02-05 |
ES2249278T3 (es) | 2006-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hsieh et al. | Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3K/Akt and ERK and JNK signaling pathways in human lung cancer cell lines | |
Luo et al. | Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer | |
Joshi et al. | Hepatoprotective potential of antioxidant potent fraction from Urtica dioica Linn.(whole plant) in CCl4 challenged rats | |
Park et al. | Inhibition of matrix metalloproteinase activities and tightening of tight junctions by diallyl disulfide in AGS human gastric carcinoma cells | |
EA200100872A1 (ru) | Композиция валдекоксиба | |
Strzemski et al. | In vitro antiproliferative activity of extracts of Carlina acaulis subsp. caulescens and Carlina acanthifolia subsp. utzka | |
Hsieh et al. | Autophagy inhibition enhances apoptosis induced by dioscin in huh7 cells | |
Jeremic et al. | The mechanisms of in vitro cytotoxicity of mountain tea, Sideritis scardica, against the C6 glioma cell line | |
Mathema et al. | Growth inhibitory effect of β‐eudesmol on cholangiocarcinoma cells and its potential suppressive effect on heme oxygenase‐1 production, STAT 1/3 activation, and NF‐κB downregulation | |
Wang et al. | Chemopreventive effects of atractylenolide II on mammary tumorigenesis via activating Nrf2-ARE pathway | |
Woo et al. | Synergistic Effect of SH003 and Doxorubicin in Triple‐negative Breast Cancer | |
Karimian et al. | The chemopreventive effect of Tanacetum polycephalum against LA7-induced breast cancer in rats and the apoptotic effect of a cytotoxic sesquiterpene lactone in MCF7 cells: a bioassay-guided approach | |
Kumar et al. | Antiproliferative activity and nitric oxide production of a methanolic extract of Fraxinus micrantha on Michigan Cancer Foundation-7 mammalian breast carcinoma cell line | |
ATE237334T1 (de) | Neue pharmazeutische zusammensetzungen von steroid-nitratester zur verwendung als enzündungshemmer | |
Kim et al. | Amentoflavone, active compound of Selaginella tamariscina, inhibits in vitro and in vivo TGF-β-induced metastasis of human cancer cells | |
Shahid et al. | Effect of Saraca asoca (Asoka) on estradiol-induced keratinizing metaplasia in rat uterus | |
Khan et al. | Anticancer potential of Phoenix dactylifera L. seed extract in human cancer cells and pro-apoptotic effects mediated through caspase-3 dependent pathway in human breast cancer MDA-MB-231 cells: an in vitro and in silico investigation | |
EA200301023A1 (ru) | Заместительная терапия эстрогенами | |
Yang et al. | Tomentosin inhibits cell proliferation and induces apoptosis in MOLT‐4 leukemia cancer cells through the inhibition of mTOR/PI3K/Akt signaling pathway | |
Li et al. | Zerumbone‐induced reactive oxygen species‐mediated oxidative stress re‐sensitizes breast cancer cells to paclitaxel | |
ATE303814T1 (de) | Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos | |
Liu et al. | Ginsenoside C‐Mx isolated from notoginseng stem‐leaf ginsenosides attenuates ultraviolet B‐mediated photoaging in human dermal fibroblasts | |
Tabasi et al. | Cytotoxic and apoptogenic properties of Nigella sativa and thymoquinone, its constituent, in human renal cell carcinoma are comparable with cisplatin | |
Girija et al. | Aristolochia bracteolata enhances wound healing in vitro through anti-inflammatory and proliferative effect on human dermal fibroblasts and keratinocytes | |
Iyyamperumal et al. | Anti-inflammatory and in vitro antioxidant potential of extracts leaves of Luffa acutangula (var) amara in rodent model (rats) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |